Swine dysentery and necrotic enteritis are a bane to animal husbandry worldwide. Some countries have already banned the use of antibiotics as growth promoters in animal production. Surfactin is a potential alternative to antibiotics and antibacterial agents. However, the antibacterial activity of Bacillus species-derived surfactin on Brachyspira hyodysenteriae and Clostridium perfringens are still poorly understood. In the current study, the antibacterial effects of surfactin produced from Bacillus subtilis and Bacillus licheniformis on B. hyodysenteriae and C. perfringens were evaluated. Results showed that multiple surfactin isoforms were detected in B. subtilis, while only one surfactin isoform was detected in B. licheniformis fermented products. The surfactin produced from B. subtilis exhibited significant antibacterial activity against B. hyodysenteriae compared with surfactin produced from B. licheniformis. B. subtilis-derived surfactin could inhibit bacterial growth and disrupt the morphology of B. hyodysenteriae. Furthermore, the surfactin produced from B. subtilis have the highest activity against C. perfringens growth. In contrast, B. licheniformis fermented product-derived surfactin had a strong bacterial killing activity against C. perfringens compared with surfactin produced from B. subtilis. These results together suggest that Bacillus species-derived surfactin have potential for development as feed additives and use as a possible substitute for antibiotics to prevent B. hyodysenteriae and C. perfringens-associated disease in the animal industry.

Necrotic enteritis caused by Clostridium perfringens has reemerged as a severe poultry disease worldwide since the ban on the routine use of antibiotics in animal feed. Probiotics are considered alternatives to antibiotic growth promoters. Bacillus species are the most common microorganisms used as probiotics in the feed industry. The current study investigated the growth and surfactin levels of Bacillus licheniformis in solid-state fermentation using different substrates and evaluated the effects of B. licheniformis -fermented products on growth performance and intestinal morphology in broilers exposed to C. perfringens . The highest viable biomass and surfactin concentration of B. licheniformis -fermented products was observed at 2% molasses and 20% soybean meal supplementation during fermentation ( P <0.05). B. licheniformis -fermented product-derived surfactin inhibited the growth of C. perfringens in vitro in a dose dependent manner ( P <0.05). B. licheniformis -fermented product supplementation (2 g/kg) significantly improved the body weight and average daily gain weight of broilers challenged with C. perfringens ( P <0.05). B. licheniformis -fermented products significantly alleviated necrotic lesions and ameliorated intestinal morphology in broilers exposed to C. perfringens ( P <0.05). Collectively, these observations demonstrate that B. licheniformis -fermented products improve growth performance and gut morphology in broilers under C. perfringens challenge. B. licheniformis -fermented products may have the potential to be used as alternatives to antibiotic growth promoters for preventive treatments against C. perfringens in broilers.

This study investigated the effects of fermented products produced by Bacillus licheniformis (fermented products) on the growth performance and cecal microbial community in broilers exposed to coccidial challenge. A total of 108 one-day-old male broiler chicks (Ross 308) were randomly allotted to one of three treatments. Each treatment was distributed into six replicate cages with six birds each. The treatments consisted of a basal diet without treatment (NC), basal diet plus coccidial challenge (PC), and basal diet plus the coccidial challenge and 1 g/kg of fermented products (FP). The results indicated that FP increased the average daily gain of broilers at 21 to 35 days of age compared with the PC group (p < 0.05). The anti-coccidia index in the FP group was elevated compared with the PC group (p < 0.05). Principal coordinate analysis showed significant segregation in bacterial community composition in the cecal digesta among the groups. The genus Lactobacillus was more abundant in the cecal digesta of the FP group compared with the PC group (p < 0.05). There was a positive correlation between the abundance of the genus Lactobacillus in the cecal digesta and growth performance (body weight, average daily gain, and average feed intake). Furthermore, the abundance of the genus Lactobacillus in the cecal digesta was positively associated with the cecal short-chain fatty acid levels (formic acid, acetic acid, propionic acid, butyric acid, and isobutyric acid). These findings suggest that fermented products produced by B. licheniformis can ameliorate the average daily gain of broilers exposed to coccidial challenge. B. licheniformis-fermented product supplementation increases anti-coccidial activity and modulates gut microbiota composition by increasing beneficial microbes and decreasing harmful microbes in broilers under coccidial challenge.

Fermented soybean meal (FSBM) has been widely investigated as a nutritional strategy for reducing the use of fish meal (FM) and antibiotic growth promoters. Microbial fermentation by using bacteria can increase the bioavailability of nutrients and reduce the levels of antinutritional factors in soybean meal (SBM). In this study, we evaluated whether FSBM produced from Lactobacillus species and Clostridium butyricum improves growth performance, diarrhea incidence, and fecal bacteria in weaning piglets. Eighty-four crossbred male piglets with an average initial body weight of 8.36±0.63 kg were randomly allotted to 3 dietary treatments consisting of 7 replicate stalls with 4 piglets each. The dietary treatments were: (1) 3% FM in the diet; (2) 5% FSBM in the diet; and (3) 3% FM in the diet plus 4 mg/kg antibiotic growth promoters (AGP). We determined that growth performance was unaffected in FSBM-fed weaning piglets compared with a FM group. Similar to the AGP group, FSBM supplementation significantly reduced diarrhea incidence in weaning piglets. The number of fecal Lactobacillus species significantly increased in 28-day-old FSBM-fed weaning piglets compared with the other groups. Compared with AGP, FSBM has the highest inhibitory effect on the number of fecal Enterobacteriaceae at 28 d old. Furthermore, serum immunoglobulin G and immunoglobulin A levels in FSBM-fed weaning piglets significantly increased at the same age. These results together indicate that FSBM can replace FM in the diets of weaning piglets without affecting growth performance. Furthermore, similar to AGP, FSBM could improve diarrhea incidence, fecal bacteria, and immunoglobulin levels in weaning piglets. Therefore, SBM fermented by Lactobacillus species and C. butyricum demonstrated high potential for development as swine feed ingredients.

Bacillus licheniformis (B. licheniformis) is commonly used as probiotic and its secondary metabolites are attractive anti-microbial candidate. In the present study, we aimed to evaluate the antiviral activity of crude extracts from B. licheniformis against porcine epidemic diarrhea virus (PEDV), a highly contagious enveloped porcine virus that has caused great economic loss in pigs. In vivo, PEDV-infected piglets supplemented with air-dried solid state fermentative cultivate containing B. licheniformis-fermented products (BLFP) showed milder clinical symptoms and decreased viral shedding. Importantly, no significant systemic pathological lesions and no reduction in average daily gain were noted in pigs supplemented with the BLFP, which suggests that it is safe for use in pigs. In vitro experiments revealed that while B. licheniformis crude extracts exhibited no toxicity in Vero cells, co-cultivation of B. licheniformis crude extracts with PEDV significantly reduced viral infection and replication. Summarized current results suggest that the B. licheniformis-fermented products could be a novel candidate food additive for reducing the impact of PED on the swine industry.